Csl Ltd Sponadr Stock Cash And Equivalents

CSJA Stock  EUR 82.00  0.50  0.61%   
CSL LTD SPONADR fundamentals help investors to digest information that contributes to CSL's financial success or failures. It also enables traders to predict the movement of CSL Stock. The fundamental analysis module provides a way to measure CSL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSL stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CSL LTD SPONADR Company Cash And Equivalents Analysis

CSL's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current CSL Cash And Equivalents

    
  668.7 M  
Most of CSL's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSL LTD SPONADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

In accordance with the recently published financial statements, CSL LTD SPONADR has 668.7 M in Cash And Equivalents. This is 18.54% lower than that of the Healthcare sector and 49.56% higher than that of the Biotechnology industry. The cash and equivalents for all Germany stocks is 75.25% higher than that of the company.

CSL Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSL's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CSL could also be used in its relative valuation, which is a method of valuing CSL by comparing valuation metrics of similar companies.
CSL is rated below average in cash and equivalents category among its peers.

CSL Fundamentals

About CSL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CSL LTD SPONADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL LTD SPONADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in CSL Stock

CSL financial ratios help investors to determine whether CSL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.